Trade Desk’s stock tumbles after earnings. Are investors being too harsh?

Stocks regained their footing after the White House announced Apple Inc.'s commitment to invest more in U.S. manufacturing.

The dollar remained under pressure and Treasury yields rose following weak debt auctions and with a Fed rate cut in September ...

Justin Pope has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ASML, Alphabet, ...

Rather, it was the Danish pharmaceutical company's No. 1 rival. Appreciative investors bid up Novo Nordisk's stock in a mini-rally that extended into Friday; the company's share price added nearly 5% ...

Palantir has its second-quarter earnings call scheduled on Aug. 4, after the market's closing bell. If it can maintain its ...

Two companies have recently seen their stock prices head higher on optimism about the future growth in AI spending. Palantir Technologies (NASDAQ: PLTR) shares are up 93% from their April low, as of ...

Palantir is taking the high ground in the artificial intelligence (AI) software revolution. The company has delivered nine ...

The One Nasdaq approach continued to accelerate cross-selling opportunities, with the company on track to surpass $100 million in run-rate revenue from cross-sells by the end of 2027. Cross-sells now ...

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 1,037%* — a market-crushing outperformance compared to 182% for the S&P 500.

Now, it’s worth noting Stock Advisor’s total average return is 1,037% — a market-crushing outperformance compared to 182 % for the S&P 500. Don’t miss out on the latest top 10 list ...

Axsome Therapeutics (Nasdaq: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, visits the Nasdaq MarketSite in Times Square to ring ...